# Docetaxel in Treating Older Women With Metastatic Breast Cancer

> **NCT00104624** · PHASE2 · TERMINATED · sponsor: **UNICANCER** · enrollment: 53 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** docetaxel
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00104624
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2007-07
- **Final completion:** 2008-07
- **Target enrollment:** 53 (ESTIMATED)
- **Why stopped:** Toxicity issues
- **Last updated:** 2013-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104624, "Docetaxel in Treating Older Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00104624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*